Search

Your search keyword '"Klein, Nigel"' showing total 755 results

Search Constraints

Start Over You searched for: Author "Klein, Nigel" Remove constraint Author: "Klein, Nigel" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
755 results on '"Klein, Nigel"'

Search Results

2. Enhanced CD95 and interleukin 18 signalling accompany T cell receptor Vβ21.3+ activation in multi-inflammatory syndrome in children

3. What more can be done? Prioritizing the most promising antenatal interventions to improve birth weight.

4. Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium

6. High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries

7. Oral Valganciclovir Initiated Beyond 1 Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Trial

8. Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali

9. Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial

10. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol

11. Improving birth weight measurement and recording practices in Kenya and Tanzania: a prospective intervention study with historical controls

12. Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial

13. What more can be done? Prioritizing the most promising antenatal interventions to improve birth weight

14. Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve counting

16. Small vulnerable newborns—big potential for impact

19. Hypothermia is not therapeutic in a neonatal piglet model of inflammation-sensitized hypoxia–ischemia

20. Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

21. Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

23. Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherence

27. Co-causation of reduced newborn size by maternal undernutrition, infections, and inflammation.

28. Preventing tuberculosis in paediatric kidney transplant recipients: is there a role for BCG immunisation pre-transplantation in low tuberculosis incidence countries?

30. Bacterial communities found in placental tissues are associated with severe chorioamnionitis and adverse birth outcomes

32. Serial blood cytokine and chemokine mRNA and microRNA over 48 h are insult specific in a piglet model of inflammation-sensitized hypoxia–ischaemia

33. Short-duration selective decontamination of the digestive tract infection control does not contribute to increased antimicrobial resistance burden in a pilot cluster randomised trial (the ARCTIC Study).

36. Evolution of CD4 T-Cell Count With Age in a Cohort of Young People Growing Up With Perinatally Acquired Human Immunodeficiency Virus.

37. Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART.

38. Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial

46. Multi-Compartment Profiling of Bacterial and Host Metabolites Identifies Intestinal Dysbiosis and Its Functional Consequences in the Critically Ill Child

48. Immunisation practices in centres caring for children with perinatally acquired HIV: A call for harmonisation

49. Development of a Pediatric Ebola Predictive Score, Sierra Leone

Catalog

Books, media, physical & digital resources